Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
1999 Nov 01;1286:1291-9. doi: 10.1038/sj.bjp.0702900.
Show Gene links
Show Anatomy links
Pharmacological similarities between native brain and heterologously expressed alpha4beta2 nicotinic receptors.
Shafaee N, Houng M, Truong A, Viseshakul N, Figl A, Sandhu S, Forsayeth JR, Dwoskin LP, Crooks PA, Cohen BN.
???displayArticle.abstract???
1 We studied the pharmacological properties of native rat brain and heterologously expressed rat alpha4beta2 nicotinic receptors immunoprecipitated onto a fixed substrate with the anti-alpha4 antibody mAb 299. 2 Immunodepletion with the anti-beta2 antibody mAb 270 showed that 89% of the mAb-299-precipitated rat brain receptors contained beta2. 3 The association and dissociation rate constants for 30 pM +/-[3H]-epibatidine binding to alpha4beta2 receptors expressed in oocytes were 0.02+/-0.01 and 0.03+/-0.01 min-1 (+/-standard error, degrees of freedom=7 - 8) at 20 - 23 degrees C. 4 The Hill coefficients for +/-[3H]epibatidine binding to the native brain, alpha4beta2 receptors expressed in oocytes, and alpha4beta2 receptors expressed in CV-1 cells (using recombinant adenovirus) were 0.69 - 0.70 suggesting a heterogeneous receptor population. Fits of the +/-[3H]-epibatidine concentration-binding data to a two-site model gave KD s of 8 - 30 and 560 - 1,200 pM. The high-affinity sites comprised 73 - 74% of the native brain and oocyte alpha4beta2 receptor population, 85% of the CV-1 alpha4beta2 receptor population. 5 The expression of rat alpha4beta2 receptors in CV-1 cells using vaccinia viral infection-transfection resulted in a more homogeneous receptor population (Hill coefficient of 1. 0+/-0.2). Fits of the +/-[3H]-epibatidine binding data to a single-site model gave a KD of 40+/-3 pM. 6 DHbetaE (IC50=260-470 nM) and the novel nicotine analogue NDNI (IC50=7-10 microM) inhibited 30 pM+/-[3H]-epibatidine binding to the native brain and heterologously expressed alpha4beta2 receptors equally well. 7 The results show that alpha4beta2-containing nicotinic receptors in the rat brain and heterologously expressed rat alpha4beta2 receptors have similar affinities for +/-[3H]-epibatidine, DHbetaE, and NDNI.
Abood,
Stereospecific 3H-nicotine binding to intact and solubilized rat brain membranes and evidence for its noncholinergic nature.
1980, Pubmed
Abood,
Stereospecific 3H-nicotine binding to intact and solubilized rat brain membranes and evidence for its noncholinergic nature.
1980,
Pubmed Buisson,
Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study.
1996,
Pubmed Cooper,
Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor.
1991,
Pubmed Covernton,
Comparison of neuronal nicotinic receptors in rat sympathetic neurones with subunit pairs expressed in Xenopus oocytes.
1994,
Pubmed
,
Xenbase Dineley-Miller,
Gene transcripts for the nicotinic acetylcholine receptor subunit, beta4, are distributed in multiple areas of the rat central nervous system.
1992,
Pubmed
,
Xenbase Duvoisin,
The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit: beta 4.
1989,
Pubmed
,
Xenbase Elroy-Stein,
Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system.
1989,
Pubmed Figl,
Two mutations linked to nocturnal frontal lobe epilepsy cause use-dependent potentiation of the nicotinic ACh response.
1998,
Pubmed
,
Xenbase Flores,
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
1992,
Pubmed Fuerst,
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
1986,
Pubmed Gerzanich,
Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
1995,
Pubmed
,
Xenbase Gossen,
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
1992,
Pubmed Hardy,
Construction of adenovirus vectors through Cre-lox recombination.
1997,
Pubmed Hill,
Immunocytochemical localization of a neuronal nicotinic receptor: the beta 2-subunit.
1993,
Pubmed Houghtling,
Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain.
1995,
Pubmed Jones,
Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.
1979,
Pubmed Lewis,
The ion channel properties of a rat recombinant neuronal nicotinic receptor are dependent on the host cell type.
1997,
Pubmed
,
Xenbase Marks,
Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit.
1999,
Pubmed Marks,
Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
1986,
Pubmed Marubio,
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits.
1999,
Pubmed Neering,
Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors.
1996,
Pubmed Peng,
Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
1994,
Pubmed
,
Xenbase Picciotto,
Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain.
1995,
Pubmed Sargent,
The diversity of neuronal nicotinic acetylcholine receptors.
1993,
Pubmed Sivilotti,
Recombinant nicotinic receptors, expressed in Xenopus oocytes, do not resemble native rat sympathetic ganglion receptors in single-channel behaviour.
1997,
Pubmed
,
Xenbase Whiting,
Purification and characterization of a nicotinic acetylcholine receptor from rat brain.
1987,
Pubmed Whiting,
Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies.
1988,
Pubmed Whiting,
Pharmacological properties of immuno-isolated neuronal nicotinic receptors.
1986,
Pubmed Whiting,
Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts.
1991,
Pubmed Zoli,
Identification of four classes of brain nicotinic receptors using beta2 mutant mice.
1998,
Pubmed Zoli,
Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems.
1995,
Pubmed
